As SMN sub-nuclear bodies (also called gems) are usually deficient in SMA patient cells, immunostaining was performed to test whether the increased SMN expression after targeted-deletion could induce nuclear accumulation of gems. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.